Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Do not start or stop BPC-157 without informing the physician managing your anticoagulation
Injection frequency depends on your individual needs
56 DongH.LocciA.KeszyckiR
Leon Shapiro, MD , Harvard-trained anesthesiologist with 25+ years in clinical and research settings
Microbial Cell
The participants were divided into the following experimental groups or a placebo group: 1 mg of retatrutide (subcutaneously) 4 mg of retatrutide (subcutaneously), starting at an initial dose of 2 mg 4 mg of retatrutide (subcutaneously), starting at an initial dose of 4 mg 8 mg of retatrutide (subcutaneously), starting at an initial dose of 2 mg 8 mg of retatrutide (subcutaneously), starting at an initial dose of 4 mg 12 mg of retatrutide (subcutaneously), starting at an initial dose of 2 mg Here are the detailed results of the trial at 24 weeks and 48 weeks: Phase II clinical trial projects promising results of retatrutide in weight management
US$ 29.23
US$ 27.57
US$ 27.05
US$ 29.78
US$ 21.95
US$ 27.19
US$ 21.07
US$ 26.30
US$ 24.35